Dall, Genevieve; Vandenberg, Cassandra J. J.; Nesic, Ksenija; Ratnayake, Gayanie; Zhu, Wenying; Vissers, Joseph H. A.; Bedo, Justin; Penington, Jocelyn; Wakefield, Matthew J. J.; Kee, Damien; Carmagnac, Amandine; Lim, Ratana; Shield-Artin, Kristy; Milesi, Briony; Lobley, Amanda; Kyran, Elizabeth L. L.; O'Grady, Emily; Tram, Joshua; Zhou, Warren; Nugawela, Devindee; Stewart, Kym Pham; Caldwell, Reece; Papadopoulos, Lia; Ng, Ashley P. P.; Dobrovic, Alexander; Fox, Stephen B. B.; McNally, Orla; Power, Jeremy D. D.; Meniawy, Tarek; Tan, Teng Han; Collins, Ian M. M.; Klein, Oliver; Barnett, Stephen; Olesen, Inger; Hamilton, Anne; Hofmann, Oliver; Grimmond, Sean; Papenfuss, Anthony T. T.; Scott, Clare L. L.; Barker, Holly E. E.

Is there a role for combined anti-PD-1/CTLA-4 checkpoint blockade in the management of advanced biliary tract cancers?

CANCER

IF5.1

2023-01-240

PRE

Pharmacokinetic and pharmacodynamic properties of the novel basal insulin Fc (insulin efsitora alfa), an insulin fusion protein in development for once-weekly dosing for the treatment of patients with diabetes

DIABETES OBESITY & METABOLISM

IF5.7

2023-01-0936

PRE

Enhancing therapeutic anti-cancer responses by combining immune checkpoint and tyrosine kinase inhibition

通过结合免疫检查点和酪氨酸激酶抑制增强治疗性抗癌反应

MOLECULAR CANCER

IF33.9

2022-09-2914

OAAI

Single-agent anti-PD-1 or combined with ipilimumab in patients with mucosal melanoma: an international, retrospective, cohort study

ANNALS OF ONCOLOGY

IF65.4

2022-09-0129

Dimitriou, F.; Namikawa, K.; Reijers, I. L. M.; Buchbinder, E., I; Soon, J. A.; Zaremba, A.; Teterycz, P.; Mooradian, M. J.; Armstrong, E.; Nakamura, Y.; Vitale, M. G.; Tran, L. E.; Bai, X.; Allayous, C.; Provent-Roy, S.; Indini, A.; Bhave, P.; Farid, M.; Kahler, K. C.; Mehmi, I; Atkinson, V; Klein, O.; Stonesifer, C. J.; Zaman, F.; Haydon, A.; Carvajal, R. D.; Hamid, O.; Dummer, R.; Hauschild, A.; Carlino, M. S.; Mandala, M.; Robert, C.; Lebbe, C.; Guo, J.; Johnson, D. B.; Ascierto, P. A.; Shoushtari, A. N.; Sullivan, R. J.; Cybulska-Stopa, B.; Rutkowski, P.; Zimmer, L.; Sandhu, S.; Blank, C. U.; Lo, S. N.; Menzies, A. M.; Long, G., V

Efficacy of anti-PD-1 and ipilimumab alone or in combination in acral melanoma

JOURNAL FOR IMMUNOTHERAPY OF CANCER

IF10.6

2022-07-0627

OAAI

Bhave, Prachi; Ahmed, Tasnia; Lo, Serigne N.; Shoushtari, Alexander; Zaremba, Anne; Versluis, Judith M.; Mangana, Joanna; Weichenthal, Michael; Si, Lu; Lesimple, Thierry; Robert, Caroline; Trojanello, Claudia; Wicky, Alexandre; Heywood, Richard; Tran, Lena; Batty, Kathleen; Dimitriou, Florentia; Stansfeld, Anna; Allayous, Clara; Schwarze, Julia K.; Mooradian, Meghan J.; Klein, Oliver; Mehmi, Inderjit; Roberts-Thomson, Rachel; Maurichi, Andrea; Yeoh, Hui-Ling; Khattak, Adnan; Zimmer, Lisa; Blank, Christian U.; Ramelyte, Egle; Kaehler, Katharina C.; Roy, Severine; Ascierto, Paolo A.; Michielin, Olivier; Lorigan, Paul C.; Johnson, Douglas B.; Plummer, Ruth; Lebbe, Celeste; Neyns, Bart; Sullivan, Ryan; Hamid, Omid; Santinami, Mario; McArthur, Grant A.; Haydon, Andrew M.; Long, Georgina, V; Menzies, Alexander M.; Carlino, Matteo S.

Pharmacokinetic and pharmacodynamic equivalence of Biocon's biosimilar Insulin 70/30 with US-licensed HUMULIN® 70/30 formulation in healthy subjects: Results from the RHINE-3 (Recombinant Human INsulin Equivalence-3) study

DIABETES OBESITY & METABOLISM

IF5.7

2022-06-064

OAAI

'Know thyself' - host factors influencing cancer response to immune checkpoint inhibitors

“了解自己”-影响癌症对免疫检查点抑制剂反应的宿主因素

JOURNAL OF PATHOLOGY

IF5.2

2022-05-2011

OAAI

Combination immunotherapy with nivolumab and ipilimumab in patients with rare gynecological malignancies: results of the CA209-538 clinical trial